Sep. 8 at 6:20 PM
$MNKD Over the past 2.5 years United Therapeutic has executed
$4 billion in share buybacks. Are the shares destined to be used for a merger with MNKD ? I'd be open to seeing United Therapeutic buy Mannkind in a cash/equity deal for between
$12 -
$15 a share for
$4 -
$5 billion, with additional future milestone payments based on regulatory and sales targets being hit. I would actually hold onto some if not most of the shares I receive from United Therapeutic to benefit from the long term upside United Therapeutic will see from the merged companies that will grow United Therapeutic from a
$20 billion company today to become a top tier pharmaceutical company with a 5 to 10 fold increase in market value. Mannkind would continue operating as a subsidiary company under United Therapeutic umbrella.
